Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

UFS Council elects new Chairperson
2017-01-27

Description: Mr Willem Louw and Nthabeleng Rammile Tags: Mr Willem Louw and Nthabeleng Rammile

Mr Willem Louw, new Chairperson of the Council
of the University of the Free State, and Dr Nthabeleng
Rammile, new Vice-Chairperson.
Photo: Stephen Collett

The Council of the University of the Free State (UFS) elected Mr Willem Louw as the new Chairperson during a special meeting on Friday 20 January 2017. He was Vice-Chairperson of the Council since 13 March 2015. Dr Nthabeleng Rammile was elected Vice-Chairperson at the same meeting, making her the first woman in the history of the university elected to this position.

The election of Mr Louw comes after the announcement by Justice Ian van der Merwe at a Council meeting on 2 December 2016 that he will be stepping down as Chairperson on 31 December 2016.

Mr Louw has served on the Council since 11 September 2009 and was elected as member of the Executive Committee of the Council on 18 November 2011. He furthermore serves on the Council’s subcommittees for Audit and Risk Management, and Honorary Degrees.

In accepting his election as Chairperson, Mr Louw said that he appreciates the trust Council has bestowed on him. “It is a privilege and honour to lead Council and I look forward to the challenge. With the support of Dr Rammile and the rest of the Council, I endeavour to ensure that the university management is assisted in the governance of the university and that the Council plays its governance role fully at all times,” he said.

“The UFS is privileged to have Mr Louw and Dr Rammile leading its Council at such a crucial time in the South African higher-education sector. Their combined experience will be of great benefit to the university community,” said Prof Nicky Morgan, Acting Vice-Chancellor and Rector of the UFS.

Mr Louw is an Associate of the Transnet Centre for Business Management of Projects at the University of Stellenbosch Business School and a non-executive Director of Group Five Limited. He was previously Managing Director of the technology business unit and a member of Group Management at Sasol, where he worked from 1985 until 2011. He is a member of the South African Council for the Project and Construction Management Professions and a Fellow of the South African Academy of Engineering. Mr Louw received his Bachelor’s and Master’s degrees in Civil Engineering from Stellenbosch University and his MDP (Management Development Programme in Project Management) from UNISA. He is currently enrolled for a PhD in Business Management and Administration at the University of Stellenbosch Business School.

Dr Rammile has served on the Council as representative of the religious communities since 1 January 2016. She is also member of the Council subcommittees for Audit and Risk Management, and Naming. She obtained a PhD in Brand Management at the UFS, where she also lectured in the Department of Business Management from 2003 to 2014. She is a pastor at Global Reconciliation, where she is responsible for women’s ministry, community outreach projects, and multimedia.

Mr Louw will serve as Chairperson of Council until 31 December 2018, and Dr Rammile will serve as Vice-Chairperson until 12 March 2018.

Released by:
Lacea Loader (Director: Communication and Brand Management)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za
Fax: +27 51 444 6393

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept